Articles dans des revues avec comité de lecture (41)
  1. 1. Baker, T. M., Lai, S., Lynch, A. R., Lesluyes, T., Yan, H., Ogilvie, H., Verfaillie, A., Dentro, S., Bowes, A. L., Pillay, N., Flanagan, A. M., Swanton, C., Spellman, P. T., Tarabichi, M., & Van Loo, P. (2024). The history of chromosomal instability in genome doubled tumors. Cancer Discovery. doi:10.1158/2159-8290.CD-23-1249
  2. 2. Salcedo, A., Tarabichi, M., Buchanan, A., Espiritu, S. M. G., Zhang, H., Zhu, K., Ou Yang, T.-H., Leshchiner, I., Anastassiou, D., Guan, Y., Jang, G. H., Mootor, M. M., Haase, K., Deshwar, A. G., Zou, W., Umar, I., Dentro, S., Wintersinger, J. A., Chiotti, K., Demeulemeester, J., Jolly, C., Sycza, L., Ko, M., PCAWG Evolution and Heterogeneity Working Group,, SMC-Het Participants,, Wedge, D. C., Morris, Q. D., Ellrott, K., Van Loo, P., & Boutros, P. C. (2024). Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction. Nature biotechnology. doi:10.1038/s41587-024-02250-y
  3. 3. Woodcock, D. D., Sahli, A., Teslo, R., Bhandari, V., Gruber, A. A., Ziubroniewicz, A., Gundem, G., Xu, Y., Butler, A., Anokian, E., Pope, B. B., Jung, C. H., Tarabichi, M., Dentro, S. S., Farmery, J. J., Van Loo, P., Warren, A. Y., Gnanapragasam, V., Hamdy, F., Bova, G. S., Foster, C., Neal, D. D., Lu, Y. J., Kote-Jarai, Z., Fraser, M., Bristow, R. R., Boutros, P. P., Costello, A. A., Corcoran, N., Hovens, C. C., Massie, C. C., Lynch, A. G., Brewer, D., Eeles, R., Cooper, C., & Wedge, D. (2024). Genomic evolution shapes prostate cancer disease type. Cell Genomics, 4(3), 100511. doi:10.1016/j.xgen.2024.100511
  4. 4. Pita, J. M., Raspé, E., Coulonval, K., Decaussin-Petrucci, M., Tarabichi, M., Dom, G., Libert, F., Ruscas-Craciun, L. I., Andry, G., Wicquart, L., Leteurtre, E., Tresallet, C., Marlow, L. A., Copland, J. A., Durante, C., Maenhaut, C., Cavaco, B. M., Dumont, J. E., Costante, G., & Roger, P. P. (2023). CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas. Frontiers in endocrinology, 14, 1247542. doi:10.3389/fendo.2023.1247542
  5. 5. Kaufmann, T., Petkovic, M., Watkins, T. B. K., Colliver, E., Laskina, S., Thapa, N., Minussi, D., Navin, N., Swanton, C., Van Loo, P., Haase, K., Tarabichi, M., & Schwarz, R. F. (2022). MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution. Genome biology, 23(1). doi:10.1186/s13059-022-02794-9
  6. 6. Paternot, S., Raspé, E., Meiller, C., Tarabichi, M., Assié, J.-B., Libert, F., Remmelink, M., Bisteau, X., Pauwels, P., Blum, Y., Le Stang, N., TABONE-EGLINGER, S., Galateau-Salle, F., Blanquart, C., van Meerbeeck, J. P., Berghmans, T., Jean, D., & Roger, P. P. (2022). Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition. Molecular Oncology. doi:https://doi.org/10.1002/1878-0261.13351
  7. 7. Steele, C. D., Abbasi, A., Islam, S. M. A., Bowes, A. L., Khandekar, A., Haase, K., Hames-Fathi, S., Ajayi, D., Verfaillie, A., Dhami, P., McLatchie, A., Lechner, M., Light, N., Shlien, A., Malkin, D., Feber, A., Proszek, P., Lesluyes, T., Mertens, F., Flanagan, A. M., Tarabichi, M., Van Loo, P., Alexandrov, L. B., & Pillay, N. (2022). Signatures of copy number alterations in human cancer. Nature (London), 606(7916), 984-991. doi:10.1038/s41586-022-04738-6
  8. 8. Drews, R. M., Hernando, B., Tarabichi, M., Haase, K., Lesluyes, T., Smith, P. S., Morrill Gavarró, L., Couturier, D. L., Liu, L., Schneider, M., Brenton, J. D., Van Loo, P., Macintyre, G., & Markowetz, F. (2022). A pan-cancer compendium of chromosomal instability. Nature (London), 606(7916), 976-983. doi:10.1038/s41586-022-04789-9
  9. 9. Bowes, A. A., Tarabichi, M., Pillay, N., & Van Loo, P. (2022). Leveraging single-cell sequencing to unravel intratumour heterogeneity and tumour evolution in human cancers. Journal of pathology. doi:10.1002/path.5914
  10. 10. Zoumpoulidou, G., Alvarez-Mendoza, C., Mancusi, C., Ahmed, R. M., Denman, M., Steele, C. C., Tarabichi, M., Roy, E., Davies, L. L., Manji, J., Cristalli, C., Scotlandi, K., Pillay, N., Strauss, S. J., & Mittnacht, S. (2021). Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma. Nature communications, 12(1), 7064. doi:10.1038/s41467-021-27291-8
  11. 11. Tarabichi, M., Demetter, P., Ruscas-Craciun, L. I., Maenhaut, C., & Detours, V. (2021). Thyroid cancer under the scope of emerging technologies. Molecular and cellular endocrinology, 541, 111491. doi:10.1016/j.mce.2021.111491
  12. 12. Yan, H., Tarabichi, M., McGranahan, N., & Van Loo, P. (2021). DeCiFering the subclonal composition of tumors. Animal Cells and Systems, 12(10), 955-957. doi:10.1016/j.cels.2021.09.008
    13. << Précédent 1 2 3 4 Suivant >>